Your shopping cart is currently empty

BI1071 is an orally active modulator of the Nur77-Bcl-2 apoptotic pathway. It binds to the Nur77-LBD protein with a Kd value of 0.17 μM. BI1071 activates the Nur77 signaling pathway and induces apoptosis by translocating to the mitochondria and interacting with Bcl-2. It inhibits tumor growth in SW620 xenograft mouse models and is applicable in colon cancer research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BI1071 is an orally active modulator of the Nur77-Bcl-2 apoptotic pathway. It binds to the Nur77-LBD protein with a Kd value of 0.17 μM. BI1071 activates the Nur77 signaling pathway and induces apoptosis by translocating to the mitochondria and interacting with Bcl-2. It inhibits tumor growth in SW620 xenograft mouse models and is applicable in colon cancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.